Reinnervate’s ec23® shown to enhance neuronal differentiation of human fetal neuroprogenitors and human embryonic stem cells
28 September 2010
Read more about Reinnervate’s ec23 and its ability to enhance neuronal differentiation as demonstrated in a paper published in Neuroscience Methods.
Reinnervate wins Chemistry Innovation / EPSRC Industrial CASE Award to fund development of Alvetex® for the 3D culture of liver cells
28 September 2010
Reinnervate has been granted a Chemistry Innovation Knowledge Transfer Network / EPSRC Industrial CASE Award to fund the development of a next-generation Alvetex® scaffold optimised for 3D hepatocyte culture.
Reinnervate has been accepted as a new member of the In Vitro Testing Industrial Platform (IVTIP)
14 September 2010
Reinnervate has been accepted into the In Vitro Testing Industrial Platform, advising European bodies on research projects in in vitro testing.
Reinnervate secures £1.8 million of investment to support commercialisation of Alvetex
27 May 2010
Reinnervate has successfully raised £1.8 million in new equity funding to complete the development of its Alvetex® 3D cell culture platform.